Flow cytometry in hematopathology: A visual approach to data analysis and interpretation

Flow Cytometry in Hematopathology: A Visual Approach to Data Analysis and Interpretation

Volumn , Issue , 2007, Pages 1-344

  Nguyen, Doyen ^a   Diamond, Lawrence W ^a   Braylan, Raul C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890002079     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-162-8     Document Type: Book

References (133)

1. Almasri NM, Duque RE, Iturraspe J, et al. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992;40:259-263.
2. Almasri NM, Iturraspe JA, Braylan RC. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles. Arch Pathol Lab Med 1998;122:539-544.
3. Arnulf B, Copie-Bergman C, Delfau-Larue M-H, et al. Nonhepatosplenic γδ T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998;91:1723-1731.
4. Behm FG, Raimondi SC, Schell MJ, et al. Lack of CD45 on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features. Blood 1992;79:1011-1016.
5. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad morphologic spectrum. Blood 1998;91:2076-2084.
6. Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989;42:567-584.
7. Blorn B, Verschuren MCM, Heemskerk MHM, et al. TCR gene rearrangements and expression of the pre-T cell receptor complex during human T cell differentiation. Blood 1999;93:3033-3043.
8. Bogen SA, Pelley D, Charif M, et al. Immunophenotypic identification of Sezary cells in the peripheral blood. Am J Clin Pathol 1996;106:739-738.
9. Borowitz MJ, Bray R, Gascoyne R, et al. U.S.-Canadian consensus recommendations on the immuno-phenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry (Commun Clin Cytometry) 1997;30:236-244.
10. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three color analysis. Am J Clin Pathol 1993;100:534-540.
11. Borowitz MJ, Shuster JJ, Civin CI, et al. Prognostic significance of CD34 expression in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol 1990;8:1380-1398.
12. Bouroncle BA. Thirty-five years in the progress of hairy cell leukemia. Leukemia Lymphoma 1994;14 (Suppl 1):1-12.
13. Bowen KL, Davis BH. Abnormal patterns of expression of CD16 (FCRgIII) and CD11b (CRIII) antigens by developing neutrophils in the bone marrow of patients with myelodysplastic syndrome. Lab Hematol 1997;3:292-298.
14. Braylan RC. Flow cytometric DNA analysis in the diagnosis and prognosis of lymphoma. Am J Clin Pathol 1993;99:374-380.
15. Braylan RC. Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasias. Cytometry Part A 2004;58A:57-61.
16. Braylan RC. Lymphomas. In: Bauer KD, Duque, RE, Shankey TV, eds. Clinical Flow Cytometry: Principles and Application. Philadelphia: Lippincott Williams & Wilkins, 1993:203-234.
17. Braylan RC, Atwater SK, Diamond LW, et al. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting. Cytometry (Commun Clin Cytometry) 1997;30:245-248.
18. Braylan RC, Benson NA, Iturraspe J. Analysis of lymphomas by flow cytometry. Current and emerging strategies. Ann NY Acad Sci 1993;677:364-378.
19. Braylan RC, Benson NA. Flow cytometric analysis of lymphomas. Arch Pathol Lab Med 1989;113:627-633.
20. Braylan RC, Orfao A, Borowitz MJ, et al. Optimal number of reagents required to evaluate hemato-lymphoid neoplasias: results of an international consensus study. Cytometry (Commun Clin Cytom-etry) 2001;46:23-27.
21. Burke JS. Are there site-specific differences among the MALT lymphomas-morphologic, clinical? Am J Clin Pathol 1999;111 (Suppl 1):S133-S143.
22. Campana D, Coutan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry (Commun Clin Cytometry) 1999;38:139-152.
23. Carulli G, Gianfaldoni ML, Azzara A, et al. FcRIII (CD16) expression on neutrophils from chronic myeloid leukemia: a flow cytometric study. Leuk Res 1992;16:1203-1209.
24. Chen J-S, Coutan-Smith E, Suzuki T, et al. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood 2001;97:2115-2120.
25. Cherian S, Moore J, Bantly A, et al. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes. Cytometry Part B 2005;64B:9-17.
26. Christensson B, Lindemalm C, Johansson B, et al. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leuk Res 1989;13:307-314.
27. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003;3:413-425.
28. Cooke CB, Krenacs L, Tetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma; a distinct clinico-pathologic entity of cytotoxic yS T-cell origin. Blood 1996;88:265-4274.
29. Cornfield DB, Mitchell DM, Almasri NM, et al. Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20. Am J Clin Pathol 2000;114:258-263.
30. Cornfield DB, Mitchell Nelson DM, Rimsza LM, et al. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells. Am J Hematol 2001;67:223-226.
31. Coutan-Smith E, Sancho J, Hankcock ML, et al. Clinical importance in minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000;96:2691-2696.
32. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764-1775.
33. Damle RN, Wasil T, Fais F, et al. IgVH gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
34. Davis BH, Foucar K, Szczarkowski W, et al. U.S.-Canadian consensus recommendations on the immu-nophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry (Commun Clin Cytometry) 1997;30:249-263.
35. De Rosa SC, Andrus JP, Perfetto SP, et al. Ontogeny of gamma delta T cells in humans. J Immunol 2004;172:1637-1645.
36. Delmer A, Ajchenbaum-Cymbalista F, Tang R, et al. Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13. Br J Haematol 1995;89:798-804.
37. Diamond LW, Bearman RM, Berry PK, et al. Prolymphocytic leukemia: flow microfluorometric, immunologic, and cytogenetic observations. Am J Hematol 1980;9:319-330.
38. Doherty PC. The function of yS T-cells. Br J Haematol 1992;81:321-324.
39. Duerig J, Nueckel H, Cremer M, et al. Zap-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 2003;17:2426-2434.
40. Dunphy CH, Dunphy FR, Visconti JL. Flow cytometric immunophenotyping of bone marrow core biopsies. Report of 8 patients with previously undiagnosed hematologic malignancy and failed bone marrow aspiration. Arch Pathol Lab Med 1999;123:206-212.
41. Duque RE, Andreeff M, Braylan RC, et al. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry 1993;14:492-496.
42. Dworzak MN, Fritsch G, Fleischer C, et al. Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow. Leukemia 1997;11:1266-1273.
43. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphomas: clinico-pathological findings and outcome. Blood 1999;93:2697-2706.
44. Gentile TC, Uner AH, Hutchison RE, et al. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 1994;84:2315-2321.
45. Gorczyca W, Weisberger J, Liu Z, et al. An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry 2002;50:177-190.
46. Harada H, Kawano MM, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993;81:2658-2663.
47. Hernandez O, Oweity T, Ibrahim S. Is an increase in CD4/CD8 T-cell ratio in lymph node fine needle aspiration helpful for diagnosing Hodgkin lymphoma? A study of 85 lymph nodes FNAs with increased CD4/CD8 ratio. Cytojournal 2005;2:14-19.
48. Huebl W, Iturraspe J, Braylan RC. FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20. Cytometry (Commun Clin Cytometry) 1998;34:71-74.
49. Hurwitz CA, Raimondi SC, Head D, et al. Distinctive immunophenotypic features of t(8, 21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992;12:3182-3188.
50. Jaffe ES. Classification of NK cell and NK-like T-cell malignancies. Blood 1996;87:1207-1210.
51. Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997;90:2863-2892.
52. Kabutomori O, Iwatani I, Koh T, et al. CD16 antigen density on neutrophils in chronic myeloproliferative disorders. Am J Clin Pathol 1997;107:661-664.
53. Kaleem Z, White G, Zutter MM. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. Am J Clin Pathol 2001;115:396-403.
54. Karandikar NJ, Hotchkiss EC, McKenna RW, et al. Transient stress lymphocytosis: an immunophenotypic characterization of the most common cause of newly defined adult lymphocytosis in a tertiary hospital. Am J Clin Pathol 2002;117:819-825.
55. Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992;80:470-477.
56. Koike T. Megakaryoblastic leukemia: the characterization and identification of megakaryoblasts. Blood 1984;64:683-692.
57. Koo CH, Rappaport H, Sheibani K, et al. Imprint cytology of non-Hodgkin's lymphomas. Based on a study of 212 immunologically characterized cases. Hum Pathol 1989;20 (Suppl 1):1-138.
58. Krasinskas AM, Wasik MA, Kamoun M, et al. The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation. Am J Clin Pathol 1998;110:797-805.
59. Kussick SJ, Fromm JR, Rossini A, et al. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol 2005;124:170-181.
60. Kussick SJ, Kalnoski M, Braziel RM, et al. Prominent clonal B-cell populations identified by flow cytometry in histologically reactive proliferations. Am J Clin Pathol 2004;121:464-472.
61. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999;13:230-240.
62. Langerak AW, van den Beemd R, Wolvers-Tettero ILM, et al. Molecular and flow cytometric analysis of the Vß repertoire for clonality assessment in mature TCRaß T-cell proliferations. Blood 2001;98:165-173.
63. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-393.
64. Leclercq G, Plum, J. Thymic and extrathymic T cell development. Leukemia 1996;10:1853-1859.
65. Lee RV, Braylan RC, Rimsza LM. CD58 decreases as non-malignant B-cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemia. Am J Clin Pathol 2005;123:119-124.
66. Li S, Eshleman JR, Borowitz MJ. Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma. Am J Clin Pathol 2002;118:229-234.
67. Liang X, Meech SJ, Odom LF, et al. Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma. Am J Clin Pathol 2004;121:496-506.
68. Lima M, Almeida J, Santos AH, et al. Immunophenotypic analysis of the TCR-Vß repertoire in 98 persistent expansions of CD3+/TCR-aß+ large granular lymphocytes. Utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol 2001;159:1861-1868.
69. Lima M, Almeida J, Teixeira Md A, et al. TCRaß+/CD4+ large granular lymphocytosis. A new clonal T-cell lymphoproliferative disorder. Am J Pathol 2003:163:763-771.
70. Lima M, Teixeira M, Queiros ML, et al. Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol Dis 2001;27:731-743.
71. Lin P Hao S, Handy BC, et al. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Pathol 2005;123:200-205.
72. Loken MR, Shah VD, Dattilio KL, et al. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987;70:1316-1324.
73. Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987;69:255-263.
74. Longacre TA, Foucar K, Crago S, et al. Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood 1989;72:543-552.
75. Look AT, Roberson PK, Williams DL, et al. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985;65:1079-1086.
76. Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993;82:1-14.
77. Macon WR, Levy NB, Kurtin PJ, et al. Hepatosplenic a/ß T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic y/S T-cell lymphomas. Am J Surg Pathol 2001;25:285-296.
78. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996;87:1474-1483.
79. Malec M, Bjorklund E, Soderhall S, et al. Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL. Leukemia 2000;15:716-727.
80. Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991;78:3269-3274.
81. Matutes E, Oscier J, Garcia-Marco J, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996;92:382-388.
82. Meyerson HJ, MacLennan G, Husel W, et al. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with Zap-70 in chronic lymphocytic leukemia. Am J Clin Pathol 2006;125:241-250.
83. Morice WG, Katzmann JA, Pittelkow MR, et al. A comparison of morphologic features, flow cytometry, TCR-Vß analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sezary syndrome. Am J Clin Pathol 2006;125:364-374.
84. Morice WG, Kimlinger T, Katzmann JA, et al. Flow cytometric assessment of TCR-Vß expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques. Am J Clin Pathol 2004;121:373-383.
85. Nathwani BN. Diagnostic significance of morphologic patterns of lymphoid proliferations in lymph nodes. In: Knowles DM, ed. Neoplastic Hematopathology. Philadelphia: Lippincott Williams & Wilkins, 2000:507-536.
86. Nguyen D, Moskowitz FB, Diamond LW. Potential diagnostic pitfalls caused by blood film artifacts in prolymphocytic leukaemia. Observations in two cases. Br J Biomed Sci 1994;51:371-374.
87. Nguyen DT, Diamond LW, Schwonzen M, et al. Chronic lymphocytic leukaemia with an interfollicular architecture: avoiding diagnostic confusion with monocytoid B-cell lymphoma. Leuk Lymphoma 1995;18:179-184.
88. Nguyen DT, Diamond LW. Diagnostic Hematology: A Pattern Approach. London: Arnold, 2000.
89. Ocqueteau M, Orfao A, Almeida J, et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998;152:1655-1665.
90. Ocqueteau M, Orfao A, Garcia-Sanz R, et al. Expression of the CD117 on normal and myelomatous plasma cells. Br J Haematol 1996;95:489-493.
91. Orchard JA, Ibbotson RE, Davis Z, et al. Zap-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004;363:105-111.
92. Orfao A, Chillon MC, Botolucci AM, et al. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARa gene rearrangements. Hematologica 1999;84:405-412.
93. Plander M, Brockhoff G, Barlage S, et al. Optimization of three-and four-color multiparameter DNA analysis in lymphoma specimens. Cytometry Part A 2003;54A:66-74.
94. Radaev S, Sun PD. Structure and function of natural killer cell surface receptors. Annu Rev Biophys Biomol Struct 2003;32:93-114.
95. Rassenti L, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893-901.
96. Reichard KK, McKenna RW, Kroft SH. Comparative analysis of light chain expression in germinal center cells and mantle cells of reactive lymphoid tissues. A four-color flow cytometric study. Am J Clin Pathol 2003;119:130-136.
97. Richards SJ, Sivakumaran M, Parapia LA, et al. A distinct large granular lymphocyte (LGL)/NK-associated (NKa) abnormality characterized by membrane CD4 and CD8 coexpression. Br J Haematol 1992;82:494-501.
98. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990;76: 2421-2438.
99. San Miguel JF, Martinez A, Macedo A, et al. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood 1997;90:2465-2470.
100. San Miguel JF, Vidriales MB, Lopez-Berges C, et al. Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification. Blood 2001;98:1746-1751.
101. Sanchez ML, Almeida J, Vidriales B, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia 2002;16:1460-1469.
102. Sausville JE, Salloum RG, Sorbara L, et al. Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene. Am J Clin Pathol 2003;119:213-217.
103. Schroers R, Griesinger F, Truemper L, et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005;19: 750-758.
104. Semenzato G, Zambello R, Starkebaum G, et al. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997;89:256-260.
105. Shin SS, Sheibani K. Monocytoid B-cell lymphoma. Am J Clin Pathol 1993;99:421-425.
106. Smets LA, Homan-Blok J, Hart A, et al. Prognostic implication of hyperdiploidy as based on DNA flow cytometric measurement in childhood acute lymphocytic leukemia-a multicenter study. Leukemia 1987;1:163-166.
107. Smith PJ, Blunt N, Wiltshire M, et al. Characteristics of a novel deep red/infrared fluorescent cell-permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy. Cytometry 2000;40:280-291.
108. Smith PJ, Wiltshire M, Davies S, et al. A novel cell permeant and far red-fluorescing DNA probe, DRAQ5, for blood cell discrimination by flow cytometry. J Immunol Methods 1999;229:131-139.
109. Spiekermann K, Emmendoerffer A, Elsner J, et al. Altered surface marker expression and function of G-CSF-induced neutrophils from test subjects and patients under chemotherapy. Br J Haematol 1996;87:31-38.
110. Spits H, Lanier LL, Phillips JH. Development of human T-and natural-killer cells. Blood 1995;85: 2654-2670.
111. Steltzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci 1993;677:265-279.
112. Stelzer GT, Marti G, Hurley A, et al. U.S.-Canadian consensus recommendations on the immunophe-notypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry (Commun Clin Cytometry) 1997;30:214-230.
113. Stetler-Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunopheno-typing in myelodysplastic syndrome. Blood 2001;98:979-987.
114. Stewart CC, Behm FG, Carey JL, et al. U.S.-Canadian consensus recommendations on the immuno-phenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry (Commun Clin Cytometry) 1997;30:231-235.
115. Tefferi A, Li C-Y, Witzig TE, et al. Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994;84:2721-2725.
116. Terstappen LWMM, Huang S, Picker LJ. Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow. Blood 1992;79:666-677.
117. Terstappen LWMM, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol 1990;2:229-240.
118. Terstappen LWMM, Safford M, Koeemann S, et al. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1991;5:757-767.
119. Terstappen LWMM, Safford M, Loken MR. Flow cytometric analysis of human bone marrow III. Neutrophil maturation. Leukemia 1990;4:657-663.
120. The non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-3918.
121. Uhrberg M, Valiante NM, Young NT, et al. The repertoire of killer cell Ig-like receptor and CD94: NKG2A receptors in T cells: clones sharing identical αβ TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J Immunol 2001;166:3923-3932.
122. van den Beemd R, Boor PPC, van Lochem EG, et al. Flow cytometric analysis of the Vβ repertoire in healthy controls. Cytometry 2000;40:336-345.
123. van Lochem EG, van der Velden VHJ, Wind HK, et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry Part B 2004;60B:1-13.
124. Vandersteenhoven AM, Williams JE, Borowitz MJ. Marrow B-cell precursors are increased in lymphomas or systemic diseases associated with B-cell dysfunction. Am J Clin Pathol 1993;100:60-66.
125. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002;20:217-251.
126. Wang S, Li N, Heald P, et al. Flow cytometric DNA ploidy analysis of peripheral blood from patients with Sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue. Am J Clin Pathol 2004;122:774-782.
127. Weisberger J, Cornfield D, Gorczyca W, et al. Down-regulation of pan-T-cell antigens, particularly CD7, in acute infectious mononucleosis. Am J Clin Pathol 2003;120:49-55.
128. Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102: 394-403.
129. Wells DA, Sale GE, Shulman HM, et al. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol 1998;110:84-94.
130. Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome and distinct gene expression profile. Blood 2003;101:4944-4951.
131. Wood BL. Flow cytometric diagnosis of myelodysplasia and myeloproliferative disorders. J Biol Regul Homeost Agents 2004;18:141-145.
132. Wu JM, Borowitz MJ, Weir EG. The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas. Am J Clin Pathol 2006;126:39-45.
133. Yuan C, Douglas-Nikitin VK, Ahrens KP, et al. DRAQ5-based DNA content analysis of hematolym-phoid cell subpopulations discriminated by surface antigens and light scatter properties. Cytometry Part B 2004;58B:47-52.